Viz.ai grabs $40m in growth funding from CIBC Innovation Banking

• The funds raised will be used by Viz.ai for expansion, including potential acquisitions
• Viz.ai’s venture capital backers include Insight Partners, Tiger Global, Kleiner Perkins, Google Ventures, Scale Venture Partners and Greenoaks Capital Partners
• CIBC Innovation Banking funds innovation companies across North America, the UK and select European countries at each stage of their business cycle

CIBC Innovation Banking has provided $40 million in growth financing to Viz.ai, a San Francisco-based company that uses artificial intelligence to expedite disease detection, inform critical care decisions and help improve patient care.

Viz.ai covers more than 220 million lives across 1,300-plus hospitals and health systems in the US and Europe. The funds raised will be used for expansion, including potential acquisitions.

“We are delighted to support Viz.ai through its rapid growth,” said Jeff Chapman, head of North American life science and healthcare, CIBC Innovation Banking, in a statement. “The company’s transformation of disease detection and workflow optimization for healthcare systems has propelled them to become a leader in the industry. CIBC Innovation Banking is proud to be involved in Viz.ai’s exciting journey ahead.”

Viz.ai’s venture capital backers include Insight Partners, Tiger Global, Kleiner Perkins, Google Ventures, Scale Venture Partners and Greenoaks Capital Partners.

CIBC Innovation Banking, the technology lending arm of Canadian bank CIBC, funds innovation companies across North America, the UK and select European countries at each stage of their business cycle, from startup to IPO and beyond.